Article

Real-world data validation of the PurIST pancreatic ductal adenocarcinoma gene expression classifier and its prognostic implications

2023-02-24

Abstract excerpt

<h4>Background</h4> Pancreatic ductal adenocarcinoma (PDAC) is amongst the deadliest cancers, with few modern tools to inform patient prognosis and help guide treatment options. Transcriptome-based molecular subtyping is one emerging technology that has been employed to help patients optimize available therapeutic approaches. Here we retrospectively demonstrate the clinical validity of PurIST (Purity Independent S...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 02c68f4e-2330-58f8-af28-1bad65c42513
DOI: 10.1101/2023.02.23.23286356

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Real-world data validation of the PurIST pancreatic ductal adenocarcinoma gene expression classifier and its prognostic implicationsDOI 10.1101/2023.02.23.23286356Read

Open-source curation of a pancreatic ductal adenocarcinoma gene expression analysis platform (pdacR) supports a two-subtype modelSemantic proximity Read

Meta-analysis of 1,200 transcriptomic profiles identifies a prognostic model for pancreatic ductal adenocarcinomaSemantic proximity Read

Bioinformatics analysis of PDAC subtypesSemantic proximity Read

Inferring Clinically Relevant Molecular Subtypes of Pancreatic Cancer from Routine Histopathology Using Deep LearningSemantic proximity Read

Minimally invasive determination of PDAC subtype and therapy-induced subtype switch by means of circulating cell-free RNASemantic proximity Read

Inferring Clinically Relevant Molecular Subtypes of Pancreatic Cancer from Routine Histopathology Using Deep LearningSemantic proximity Read

MetaPaCS: A Novel Meta-Learning Framework for Pancreatic Cancer Subtype IdentificationSemantic proximity Read

Decoding the GPRC5A Paradox in Pancreatic Ductal Adenocarcinoma:A Subtype-Stratified, Treatment-Deconfounded, Multi-Omic InvestigationSemantic proximity Read

A transcriptomics-based meta-analysis combined with machine learning approach identifies a secretory biomarker panel for diagnosis of pancreatic adenocarcinomaSemantic proximity Read

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancerSemantic proximity Read

Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-derived organoidsSemantic proximity Read

Pancreatic cancer survival analysis defines a signature that predicts outcomeSemantic proximity Read